Published by Josh White on 26th April 2018
(WebFG News) - Advanced transdermal technology-focussed healthcare company Futura Medical updated the market on the planned phase III trials for MED 2002, its topical gel for erectile dysfunction, on Thursday.
URL: http://www.digitallook.com/dl/news/story/27388253/...